FDG-PET provides information on glioma tumor before gene therapy

11/23/2009 | HealthImaging.com

German researchers used the herpes simplex virus type 1 thymidine kinase gene as a marker for the noninvasive in vivo PET imaging of thymidine kinase expression associated with malignant glioma. The researchers also used an F18-labeled tracer to gain information on tumor tissues before gene therapy.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA